• 13 February 2019

    MHRA recalls a further three batches of sartan-based products

    The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced it has recalled three more batches of irbesartan as part of its continued investigation into potential N-nitrosodiethylamine (NDEA) contamination...

  • 12 February 2019

    FDA clamps down on illegal dietary supplements

    The US Food and Drug Administration (FDA) has announced new measures to strengthen its regulation and oversight of dietary supplements, which have not been reviewed by the regulator.

Go Top